ECIO 2015

22/04/2015 - 25/04/2015
Nice (France)

 

APRIL 2015
CT, MRI, PET imaging side by side with Real-Time Ultrasound.

Explore innovative clinical solutions in radiology, including liver and other abdominal interventions, urology, MSK, peripheral vascular and transcranial radiological exams..
Come and discover at ECIO 2015



Discover EVOlution '15, the latest program enhancement for Esaote Ultrasound systems: bringing increased image quality, new technologies and boosted productivity.

The Esaote Clinical Solutions Focused on Interventional Oncology
Dedicated Probe for 0° Biopsy
& Percutaneous
Procedure Guidance


SI2C41 iQprobe is dedicated to Biopsy and Percutaneous Interventional Procedures ...
Advanced Biopsy even in
very difficult approaches
 


Virtual Biopsy allows physicians to follow percutaneous procedures with increased confidence ...


IOT342
A probe designed
by a surgeon for surgeons


IOT342 is the new
intra-operative T probe with wide multi-band frequency ...

MyLabTMAlpha

MyLab™Alpha eHD CrystaLine: Top Performance in Action focused on the real diagnostic value, the premium performance portable ultrasound system

MyLabTMTwice

MyLab™Twice eHD CrystaLine: Two Ways To Be Unique for premium performance and point-of-care ultrasound outstanding results.

Committed to Education

Join the International School of IntraOperative UltraSound on Liver (I.O.U.S.) and find place ...

EchoLaser

EchoLaser, The New Approach to Minimally Invasive Technique, is the first and unique integrated system dedicated to diagnostic Ultrasound and Laser thermal ablation therapy ...

Technology and features are system/configuration dependent. Specifications are subject to change without notice. Information may refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative.
This page uses cookies. Visiting this web site, you approve the use of cookies. For more information about the use of cookies in this web site, please click on “More information”. I agree More information